We abstained from any interference with the exception of interrupting the pregnancy when this was requested by the parents and considered feasible by us if the length of gestation was appropriate. This policy was based on two considerations. First, the morphologic information about the fetal lesion(s) obtained with ultrasound is limited compared with what one would consider adequate when planning treatment of the neonate or the infant. Second, intervention is undertaken in the belief that the evolution of the lesion and its deleterious effects on the proximal organ (i. e., the kidney) are still in an early stage and will be reversed by decompression. However, it is questionable that any fetal lesion that can be detected by ultrasound can be regarded to be an "early" lesion. Weighing the above considerations against the parental anguish and stress, and even the possible risk associated with surgical intervention, we concluded that an expectant policy was neither irrational nor unethical.
During the study period considerable experience has accumulated, and as a result at present many criteria are available for the recognition of cases in which treatment would not be expected to be helpful [7, 16] . These criteria relate to the type of lesion and its effect on kidney function at the time of diagnosis, the chances of fetal survival as determined by lung hypoplasia, associated lesions, karyotype, and the duration of gestation at the time of diagnosis. These criteria were applied in the retrospective analysis of our cases.
It is clear that in utero decompression of urinary obstruction should not be attempted in the mature fetus [7, 16] . More difficult to answer is the question of the stage of pregnancy in which treatment must be attempted. The general trend in the literature seems to indicate that lesions rated before the 20th week are irreversibly deleterious to the kidney, because division of the metanephrogenic ampulla and formation of the excretory system start to slow down in the 13th or 14th week(s) and this process is completed by the 20th week [12] .
Associated malformations and chromosomal anomalies are frequent [5, 12] , and are especially important with respect to meaningful survival of the neonate. However, an ultrasonographic search for minor associated anomalies, particularly in the absence of liquor amnii, is often unrewarding.
The type of urinary lesion is of course a major determinant of success. Renal agenesis and extreme hypoplasia (Potter, type lib) are clearly not amenable to treatment but must be included when an analysis of the benefit resulting from ultrasonic diagnosis is performed iri a population of babies. Nor should polycystic kidney disease be treated [11] . On the other hand, therapy is usually unnecessary in cases of stenosis of the pelvi-ureteric junction [11] and is only exceptionally indicated in cases with unilateral lesions [16, 17] , namely when the volume of the hydroureter/hydronephrosis threatens fetal wellbeing or impedes the outflow of the contralateral kidney. Nonobstructive forms of prune belly syndrome are not amenable to treatment [2] .
In the category that can be treated, e.g. fetuses with bilateral obstructive lesions not associated with other malformations, reasonably good kidney function must be anticipated before surgical intervention is attempted. Ultrasonic signs are not very reliable indices for judging kidney function [4, 5, 8, 9, 10] ; the most sensitive test is assessment of fetal natriuria [3, 4] . Renal function may be considered normal when the concentration of sodium is lower than 50 mMol/1. The crucial factor that determines neonatal survival, i.e., the presence of lung hypoplasia, cannot be reliably assessed antenatally as yet.
Results
In table II we have listed the occurrence of the above mentioned factors which contraindicated intrauterine treatment in our cases. In each of our cases at least one (and in most instances several) factors were identified that either rendered intrauterine treatment superfluous or precluded its success. Indeed, in bilateral renal agenesis (cases 2, 7 and 19) there is no available treatment and the same holds for extreme hypo-and dysplasia (cases 9 and 13), which cannot be distinguished ultrasonically from renal agenesis. Cases 4 and 12 belong to the category of cystic dysplasias where intervention cannot be beneficial. Furthermore, the duration of pregnancy contraindicated intrauterine therapy in these cases. Cases 3, 5, and 6 had unilateral lesions. Case 16 showed an early, transient, unilateral lesion that was asymptomatic in the neonate. Case 17 was a stable hydronephrosis due to reflux; neither the character of the lesion nor the duration of the pregnancy justified intrauterine treatment. This case was complicated by premature membrane rupture and placental abruption; on these grounds the fetus was delivered by cesarean section and did well (table III) .
Without exception, the fetuses with bilateral obstruction developed the full-blown prune belly syndrome. In case 18, anhydramnios was already established at week 17. At the other end of the scale, case 14 could not be considered for intrauterine therapy because the pregnancy was too far advanced. The prune belly was not caused by obstruction: there was multiple abnormalities and the baby had trisomy 13. In cases 1 and 15 the prune belly syndrome was non-obstructive. In the first of these, anhydramnios was associated with pulmonary hypoplasia and amnion nodosum, with adhesion to the entire fetal back. In the latter, besides the extreme malformation, renal function was no longer optimal (natriuria 58 mMol/1).
Of the cases with obstructive lesions (nos. 8, 10, and 11), no. 11 showed urinary ascites with per- sisting urine production as assessed by repeat puncture, but at post-mortem examination, two weeks after diagnosis, this infant displayed extreme renal dysplasia with cartilaginous degeneration and marked pulmonary hypoplasia; moreover, serious cloacal malformation (atypical urethral and rectal communication with vaginal agenesis) was responsible for the obstruction. Case 10, seen at week 32, had posterior urethral valves and was treated successfully after birth.
On the basis of the available evidence we may safely conclude that from the moment the diagnosis was established, none of the fetuses in our series would have benefited from intrauterine treatment.
Discussion
The results reported in the literature show that intrauterine treatment of urinary tract anomalies can only be expected to be successful in carefully selected cases, and such candidates represent only a tiny fraction of those detected at the time of ultrasound examination. MCFADYEN [12] mentioned 5 survivals among a total of 11 fetuses treated, but a later report [13] indicated that at the time of writing only one of them was still alive. THOMAS [19] noted only one survivor out of 8. BLANE et al. [2] analyzed 9 cases and concluded that only one child would have benefited from intrauterine intervention, and of 29 additional cases reviewed by these authors the tentative benefit ratio was 6/38. According to the experience of GALLEN [3, 4] and CAMPBELL [5] , a 10% benefit ratio can be expected. This fraction may still include neonates who would have done well without intrauterine treatment, and a long-term beneficial effect on renal function has not yet been established for such children.
It seems obvious that fetal treatment has no place when extrauterine treatment would be timely and feasible, but it is not yet clear at what gestational age treatment should be started and thus regarded as a feasible alternative to interruption of the pregnancy. According to the MANNING registry [11] , 11 out of 30 fetuses were treated by vesicoamniotic shunting prior to week 20. Six of them succumbed, which suggests that the group treated prior to the 20th week is the most favorable one (6/11 survivals vs. 3/8 before week 25 and 3/11 after week 25). This appears to be at odds with the authors' own conclusion that, in general, "it seems likely that the earlier in gestation the scan occurs, the more overt the disease process must be to be recognized", which corresponds to the experience of others [7, 14, 15] . A possible explanation for this divergence in opinion is that con-tributors to MANNING'S registry treated some early cases that had not needed any treatment.
Functional evaluation before intervention is still a problem, and visualization of a parenchymatous mantle around a hydronephrotic kidney does not constitute conclusive proof that kidney function is intact [10] . Ultrasonographic clues pointing to integrity of the kidney parenchyma are few and inconsistent. Increased cortical echogenicity denotes dysplasia to some extent [5] , but this sign is not wholly reliable [4] because it can be a normal finding in neonates and in infants [8] . The combination of an empty bladder and dilated kidneys means that renal dysplasia has occurred to a degree that renders any treatment futile [9] . There can be two consequences for the obstructed bladder, either muscular hypertrophy or rupture with consequent spilling of urine into the abdominal cavity of the fetus. The latter event leads to urinary ascites and this may temporarily relieve pressure on the renal parenchyma [18] . Urinary ascites is not always due to rupture but can also result from diffusion of urine through the immature transitional epithelium of the bladder if this is obstructed early in pregnancy [10] . Hypertrophy is present if the wall of the bladder is visible ultrasonographically, which normally is not the case. When intravesical calcifications accompany urinary ascites, the fetal prognosis is hopeless [4] .
Analysis of fetal urine (obtained by puncture ) is obligatory for further evaluation of renal function. The assay of creatinine is virtually useless for this purpose, because in large measure the excretory function of the fetus is taken by the placenta. According to DAFFOS [6] , the fetal creatinine level determined in umbilical blood is related to maternal creatininemia, not to fetal renal function. The most sensitive parameter available is fetal natriuria [3, 4] : renal function can be considered normal when the concentration of sodium is lower than 50 mMol/1. When it is more than 100 mMol/1 the fetus is a salt loser, which means that kidney function has been lost. Between these concentrations there is an intermediate area in which other criteria, based on ultrasonography, should influence the decision concerning treatment.
The most distressing feature of our cases was the high incidence of renal and pulmonary hypoplasia. To put this in perspective, it should be noted that in almost all of the cases (the exception being no. 11, where the parents asked for a two weeks delay, and no. 16, where the lesion was apparently innocent and transient) the pregnancy ended, either spontaneously or was terminated, within the week following final diagnosis. It may be assumed that the findings relating to kidney and lung pathology reflected the situation at the time of diagnosis. In any case, serious treatment programs reportedly require more than a single week of investigations before treatment can be started. It would seem that most cases are already far beyond treatment before they are detected by routine ultrasound examination.
Conclusions
Retrospective analysis of 19 consecutive cases of fetal urinary tract malformations showed that all of them presented at least one feature which, according to current opinion, renders intrauterine treatment superfluous or futile. In this series, active intervention would not have altered the outcome even in a single case.
Summary
To assess the potential value of intrauterine diversion in cases of fetal urinary tract malformation, we re-evaluated the 19 cases of such lesions which were part of a consecutive series of 94 cases of fetal malformations that were diagnosed in our department between 1980 and 1985 (table I) . We chose a policy of non-interference for two reasons: Firstly the relative paucity of available data compared with what one would normally expect to obtain when planning a treatment of the newborn, and secondly the expectation that the benefit in terms of recovery of function would be minimal, because a lesion observable on even early echography is more than trivial, and no longer "early" in an ontogenic sense. The empirical criteria which indicate that intrauterine intervention is either futile or superfluous, noted in the literature, were applied in a retrospective study of-our cases and evaluated in relation to the data of pregnancy duration, clinical outcome (tables II and III), and pathological findings in the urinary tract and other systems. The criteria include: the character of the urinary tract malformation, i.e. incompatible with survival (renal agenesis or aplasia, polycystic dysplasia), benign (unilateral lesion, non-evolving lesions), or those unlikely to be influenced by diversion (non-obstructive lesions); associated lesions or chromosomal anomalies incompatible with possible or meaningful survival; functional parameters, i. a., oligo-or anhydramnios, fetal natriuria indicative of serious renal malfunction, and bladder calcification; pathological findings such us kidney dysplasia which is an irremediable lesion or lung dysplasia incompatible with neonatal survival; and, finally, duration of pregnancy when important early lesions point to a highly compromised fetal situation; or a late diagnosis constitutes an indication for delivery and subsequent postnatal evaluation and treatment. All of our 19 cases (table II) were found retrospectively to have shown at least one and usually several of these features, each of which is an indication that intrauterine treatment will be either superfluous or useless. We conclude that in the present series a policy advocating intrauterine intervention would not have led to any beneficial change in the outcome.
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